Reversal of long-term dendritic spine alterations in Alzheimer disease models
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Synapse loss is strongly correlated with cognitive impairment in Alzheimer's disease (AD). We have previously reported the loss of dendritic spines and the presence of dystrophic neurites in both the hippocampi of transgenic mice overexpressing amyloid precursor protein (APP) and in the human brain affected with AD. In the studies reported here we have asked whether the acute alterations in dendritic spines induced by Aβ, as well as the chronic loss of spine density seen in hAPP transgenic mice, are reversible by treatments that restore the cAMP/PKA/CREB signaling pathway or proteasome function to control levels. The results show that both rolipram and TAT-HA-Uch-L1 restore spine density to near control conditions, even in elderly mice. The results suggest that changes in dendritic structure and function that occur after Aβ elevation are reversible even after long periods of time, and that one could envision therapeutic approaches to AD based on this restoration that could work independently of therapies aimed at lowering Aβ levels in the brain.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, at least some evidence suggests structural and functional alterations may be reversible pharmacologically, opening new therapeutic directions in Alzheimer’s disease98.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [98]
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · cited 3×
“Terry RD, et al. (1991) Physical basis of cognitive alterations in Alzheimer’s disease: Synapse loss is the major correlate of cognitive impairment.”
BackgroundCorrelative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210 · cited 2×
“Double transgenic APP/PS1 mice were obtained by crossing hemizygous transgenic mice (HuAPP695SWE; line tg2576) expressing mutant human APP K670N, M671L (35) with hemizygous PS1 mice that express mutant human PS1M146V (line 6.2) (36).”
BackgroundInfluentialPathways towards and Away from Alzheimer’s Disease
Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052 · cited 2×
“The changes confirm our earlier studies showing similar changes in both J20 single transgenic and APP/PS1 double transgenic animals and in human AD brain (1).”
BackgroundResultAlzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516 · cited 1×
“The development of A plaques has been successfully achieved in transgenic mice overexpressing mutated forms of APP (4) and is greatly accelerated in transgenic models overexpressing mutated forms of both APP and PS1 (5).”
BackgroundWolfe, M. S., Xia, W., Ostaszewski, B. L., Diehl, T. S., Kimberly, W. T., & Selkoe, D. J. (1999) · Nature · doi:10.1038/19077 · Cited by 1,916
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856
Matsuzaki, M., Ellis-Davies, G. C. R., Nemoto, T., Miyashita, Y., Iino, M., & Kasai, H. (2001) · Nature Neuroscience · doi:10.1038/nn736 · Cited by 1,802
Shankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592 · cited 1×
“Dendritic spine loss is also seen in the brains of PDAPP, Tg2576, and J20 APP transgenic mice (27, 28) and in hippocampal slices treated with A (29, 30).”
BackgroundIncreased amyloid-β42(43) in brains of mice expressing mutant presenilin 1
Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C.-M., Perez-tur, J., Hutton, M., Buee, L., Harigaya, Y., Yager, D., et al. (1996) · Nature · doi:10.1038/383710a0 · Cited by 1,465
Cited by
Items 201–238 of 238
Cortese, G. P., Bartosch, A. M. W., Xiao, H., Gribkova, Y., Lam, T. G., Argyrousi, E. K., Sivakumar, S., Cardona, C. L., & Teich, A. F. (2024) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlae033 · Cited by 1
Unlocking the therapeutic promise of miRNAs in promoting amyloid-β clearance for Alzheimer's disease
Kaur, V., & Sunkaria, A. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115505 · Cited by 1
Tracking the morphological evolution of neuronal dendrites by first-passage analysis
Kreten, F. H., Niemeyer, B. A., Santen, L., & Shaebani, M. R. (2025) · Biophysical Journal · doi:10.1016/j.bpj.2025.11.005 · Cited by 1
“On the other hand, reversal of morphological changes upon treatment has also been re-ported (35,36).”
Threlfell, S., & West, A. R. (2014) · Wiley eBooks · doi:10.1002/9781118836507.ch11 · Cited by 1
Zhou, J., Zhai, S., Zhang, H.-N., Wang, Y., & Pu, X. (2015) · Brain Research · doi:10.1016/j.brainres.2015.06.051 · Cited by 1
Structural Alterations of Synapses in Psychiatric and Neurodegenerative Disorders
Penzes, P., Remmers, C. L., Cahill, M. E., Jones, K. A., VanLeeuwen, J., & Woolfrey, K. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418675-0.00009-2 · Cited by 1
Alzheimer’s Disease and Mechanism-Based Attempts to Enhance Cognition
Draffin, J. E., Knafo, S., & Heneka, M. T. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-417042-1.00009-7 · Cited by 1
Stephens, G. S., You, J. C., Fu, C.-H., & Chin, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.21126-7 · Cited by 1
Vogel III, E. W. (2017) · Columbia Academic Commons (Columbia University) · doi:10.7916/d8p273tk · Cited by 2
Gorny, N., & Kelly, M. P. (2021) · Vitamins and hormones · doi:10.1016/bs.vh.2020.12.012 · Cited by 1
Chabrier, M. A., Neely, K. M., Castello, N. A., & LaFerla, F. M. (2011) · Royal Society of Chemistry eBooks · doi:10.1039/bk9781849731843-00001 · Cited by 2
Synaptic elimination and the complement system in Alzhaimer's disease
Daborg, J. (2012) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Chapter 22 Molecular and Cellular Neuromodulation for Central Nervous System Injury and Regeneration
Carlstrom, L. P. (2016) · Pan Stanford Publishing eBooks · doi:10.1201/9781315364759-23
Russo, S. J., & Han, M. (2017) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.731077746.793537883
Rodent models of Alzheimer’s disease
Kasza, Á. (2018) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.9743
Tan, Y., Fang, H., Li, J., Zhang, Y., Yi, L.-S., Zhang, C., Xu, Z., Wang, Y., Zhang, J., Wei, P., et al. (2018) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000448
“What’s more, according to clinical studies, the loss of synapses has been considered as one of the most reliable index of cognition deficits in both post-mortem and biopsied AD brain [27]; and amyloid deposition or Aβ peptide (either insoluble Aβ or soluble Aβ species) is associated with synaptic abnormalities, such a…”
Background(2020) · PeerJ · doi:10.7287/peerj.10003v0.2/reviews/1
“This finding was supported by a previous study where this signaling pathway has been shown to be impaired by Aβ in cultivated cells or brain slices treated with oligomeric Aβ and in vivo as demonstrated by mouse models of transgenic AD (Vitolo et al., 2002; Smith et al., 2009).”
ResultDevelopment of demetia therapeutics regurating synaptic plasticity
Fukunaga, K. (2023) · Folia Pharmacologica Japonica · doi:10.1254/fpj.22138
Perturbations to Stimulus-Dependent Gene Activity Patterns in Neurodegenerative Disorders
Madabhushi, R., & Tsai, L. (2024) · Springer eBooks · doi:10.1007/978-3-031-68550-7_15
Su, X., Chen, H., Cao, J., Zhang, Y., Kang, Y., Wang, L., Yin, J., & Jing, Y. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251379079
“40 In this study, the abnormal dendritic morphology and decreased dendritic spine density in the DG areas were consistent with the reduction of pCreb in whisker-deprived 5 × FAD mice.”
The role of Hsp20 in Alzheimer's disease
Cameron, R. T. (2014) · Enlighten: Theses (The University of Glasgow)
Acuña-Catalán, D. (2023) · Universidad de Chile · doi:10.58011/wkj1-8t82
Català-Solsona, J. (2020) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Rebaud, S. (2015) · theses.fr (ABES) · doi:10.70675/9ea33832za5aaz4dcez822fz64e543bae8e6 · Cited by 2
Hallé, F. (2015) · theses.fr (ABES) · doi:10.70675/406770b6z4f47z49cfz9a2dz8f123968b8fa · Cited by 1
Valverde, A. (2020) · theses.fr (ABES) · doi:10.70675/f1b70734zf4e3z4870z8fbdz950d831642a7
AETA, a new neuromodulator of hippocampal NMDA receptors and its implication in Alzheimer's disease
Dunot, J. (2024) · theses.fr (ABES) · doi:10.70675/72878d27zd2ccz46a5zb38dz431fe3d74ec5
BindingDB (2016) · UC San Diego · doi:10.7270/q29888rc
BindingDB (2020) · UC San Diego · doi:10.7270/q22b91mk
Mohanty, S., Bosworth, S., Ramaswamy, K., Natarajan, C., & Krishnan, B. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.26.762038
Impact of stress exposure and pharmacological intervention on a mouse model of Alzheimer’s disease
Sierksma, S. R. (2012) · Research Publications (Maastricht University) · doi:10.26481/dis.20121220ss
Chassefeyre, R. (2013) · theses.fr (ABES) · doi:10.70675/3b8c63cczc297z4d27zb201ze551f7cfa61a
Metadata
- Authors
- Smith, D. L., Pozueta, J., Gong, B., Arancio, O., & Shelanski, M.
- Affiliations
- Columbia University (US)
- Guy's Hospital (GB)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2009-09-29
- Volume
- 106
- Issue
- 39
- Pages
- 16877-16882
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2743726
- OpenAlex
- W1977390447
- Cited by
- 229
- References
- 42
- Citations by year
- 2026: 1 · 2025: 10 · 2024: 7 · 2023: 9 · 2022: 6 · 2021: 7 · 2020: 21 · 2019: 10 · 2018: 16 · 2017: 20 · 2016: 10 · 2015: 17 · 2014: 22 · 2013: 18 · 2012: 23
- FWCI
- 12.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (AG 008700)
- National Institute of Neurological Disorders and Stroke (NS15076, R01NS015076)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, dendritic spines, synaptic loss, amyloid-beta, APP transgenic mice, rolipram, cAMP/PKA/CREB signaling, proteasome function, UCHL1, dystrophic neurites, hippocampus, cognitive impairment
- MeSH terms
- Alzheimer Disease, Animals, Brain, Dendrites, Disease Models, Animal, Hippocampus, Humans, Mice, Transgenic, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Dendritic Spines, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.